No Data
No Data
Beijing Succeeder Technology's (SHSE:688338) Solid Earnings May Rest On Weak Foundations
Beijing Succeeder Technology Inc. (SHSE:688338) just released a solid earnings report, and the stock displayed some strength. However, we think that shareholders should be cautious as we found some w
Secoside (688338): Revenue and profit have been growing steadily for 23 years, and innovative products have continued to be launched
Incident: Recently, the company released its annual report for 2023 and the first quarter report for 2024. In 2023, the company achieved revenue of 275 million yuan, an increase of 20.40% over the previous year; achieved net profit of 117 million yuan to mother
Secoside (688338.SH) reported 2023 results, net profit of 117 million yuan, an increase of 12.29% year-on-year
Secoside (688338.SH) released its 2023 annual report, achieving revenue of 275 million yuan, with...
Secoside (688338): The sales side continues to grow quarter by quarter, waiting for the number of high-speed machines to be installed
Seccoside announced its 2023 annual report and 2024 quarterly report. The company achieved operating income of 276 million yuan in 2023, +20.4% year over year; net profit to mother was 117 million yuan, +12.3% year over year; no return was deducted
Secoside (688338.SH): Overseas markets are important markets with potential for future development of domestic coagulation testing equipment
GLONGHUI, March 11丨Secoside (688338.SH) recently said during an investigation by institutional investors that the company's products, such as blood coagulation testers, reagents, and blood sedimentation testers, have been exported to Turkey, Iran, India, Vietnam, Peru and other countries. The company attaches great importance to the development of overseas business. The overseas market is an important market with potential for future development of domestic coagulation testing equipment. In the future, the company will strive to increase overseas business revenue. In 2023, the company's fully automatic coagulation analyzer passed the European Union IVDRCE registration, laying the foundation for future expansion of the international market.
Secoside (688338.SH): The coagulation line has been tested offline and will be launched on the market in the first half of this year
Gelonghui, March 11 | Secoside (688338.SH) recently said during a survey receiving institutional investors that the coagulation line has been tested offline and will be launched on the market in the first half of this year. The coagulation line mainly faces the customer groups of the top three hospitals, helping the company improve its customer level and meet the growing demand for coagulation testing in the top three hospitals.
No Data